Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peramivir intramuscular single-dose trial for uncomplicated influenza
ACTRN12607000284460Phase 2Recruiting
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- May 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of peramivir in influenza (3 arms), sponsored by BioCryst Pharmaceuticals, Inc. Primary endpoint: Efficacy of peramivir versus placebo in uncomplicated acute influenza. Started May 2007; status: recruiting.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12607000284460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000284460.